Skip to main content

Table 3 Total number of consultations provided by general practitioners per population

From: A mixed-method study on the provision of remote consultations for non-communicable disease patients during the first wave of the COVID-19 pandemic in Latvia: lessons for the future

 

No. of consultations per 100,000 populationa per day (95% CI)

2019

2020

Difference between 2020 and 2019, p-value

Difference within 2020, p-value

C50: surgeons

 Period I-III

1.17 (1.11; 1.23)

1.28 (1.22; 1.34)

0.11 (0.03; 0.20), 0.006

 

 Period I

1.14 (1.06; 1.23)

1.36 (1.27; 1.46)

0.22 (0.09; 0.35), < 0.001

 Period II

1.06 (0.97; 1.16)

1.13 (1.10; 1.23)

0.07 (−0.06; 0.20), 0.306

 Period III

1.35 (1.23; 1.47)

1.35 (1.23; 1.48)

0.00 (−0.17; 0.17), 0.983

  Period II vs Period I

   

−0.23 (− 0.36; − 0.10), < 0.001

  Period III vs Period II

0.22 (0.06; 0.37), 0.005

  Period III vs Period I

−0.01 (− 0.17; 0.14), 0.874

C61: urologists

 Period I-III

5.61 (5.48; 5.75)

5.66 (5.52; 5.80)

0.05 (−0.14; 0.24), 0.609

 

 Period I

5.65 (5.44; 5.87)

6.13 (5.91; 6.36)

0.48 (0.17; 0.78), 0.002

 Period II

5.59 (5.36; 5.83)

4.35 (4.14; 4.56)

−1.24 (− 1.56; − 0.93), < 0.001

 Period III

5.57 (5.30; 5.84)

6.63 (6.34; 6.93)

1.07 (0.66; 1.47), < 0.001

 Period II vs Period I

   

− 1.78 (−2.09; − 1.48), < 0.001

 Period III vs Period II

2.28 (1.92; 2.65), < 0.001

  Period III vs Period I

0.50 (0.13; 0.87), 0.008

E10, E11: endocrinologists

 Period I-III

16.88 (16.72; 17.04)

16.39 (16.24; 16.55)

−0.48 (− 0.71; − 0.26), < 0.001

 

 Period I

17.47 (17.23; 17.72)

18.23 (17.97; 18.49)

0.76 (0.40; 1.11), < 0.001

 Period II

15.75 (15.48; 16.01)

13.10 (12.86; 13.34)

−2.65 (− 3.01; − 2.29), < 0.001

 Period III

17.39 (17.07; 17.71)

17.73 (17.41; 18.06)

0.34 (−0.12; 0.80), 0.144

 Period II vs Period I

   

−5.13 (− 5.48; − 4.78), < 0.001

  Period III vs Period II

4.63 (4.23; 5.04), < 0.001

  Period III vs Period I

−0.50 (− 0.91; − 0.08), 0.019

I10, I20-I25, I50: cardiologists

 Period I-III

11.49 (11.36; 11.62)

10.20 (10.07; 10.32)

−1.29 (− 1.47; − 1.11), < 0.001

 

 Period I

12.09 (11.88; 12.30)

13.55 (13.33; 13.78)

1.46 (1.16; 1.76), < 0.001

 Period II

11.13 (10.90; 11.35)

5.27 (5.11; 5.42)

−5.86 (− 6.13; − 5.59), < 0.001

 Period III

10.95 (10.70; 11.21)

11.17 (10.92; 11.44)

0.22 (− 0.14; 0.58), 0.236

  Period II vs Period I

   

−8.29 (− 8.56; − 8.02), < 0.001

  Period III vs Period II

5.91 (5.61; 6.21), < 0.001

  Period III vs Period I

−2.38 (− 2.72; − 2.04), < 0.001

J44, J45: pulmonologists and/or allergist

 Period I-III

5.80 (5.71; 5.89)

5.05 (4.97; 5.14)

−0.75 (− 0.87; − 0.62), < 0.001

 

 Period I

6.13 (5.98; 6.28)

6.49 (6.34; 6.64)

0.36 (0.15; 0.57), < 0.001

 Period II

5.63 (5.48; 5.80)

3.25 (3.12; 3.37)

−2.39 (− 2.59; − 2.19), < 0.001

 Period III

5.46 (5.28; 5.64)

5.07 (4.89; 5.24)

−0.40 (− 0.65; − 0,14), 0.002

  Period II vs Period I

   

−3.24 (− 3.44; − 3.05), < 0.001

  Period III vs Period II

1.82 (1.61; 2.03), < 0.001

  Period III vs Period I

−1.42 (− 1.65; − 1.19), < 0.001

  1. a Female and male populations for breast and prostate cancer consultations, respectively